The store will not work correctly when cookies are disabled.
N-(4-amino-3-nitrophenyl)benzenesulfonamide
ID: ALA4751828
PubChem CID: 8452407
Max Phase: Preclinical
Molecular Formula: C12H11N3O4S
Molecular Weight: 293.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(NS(=O)(=O)c2ccccc2)cc1[N+](=O)[O-]
Standard InChI: InChI=1S/C12H11N3O4S/c13-11-7-6-9(8-12(11)15(16)17)14-20(18,19)10-4-2-1-3-5-10/h1-8,14H,13H2
Standard InChI Key: GQTSATIPZYKDAN-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
31.5650 -16.2406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1606 -15.5349 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.7516 -16.2380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5789 -15.5349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5778 -16.3544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2858 -16.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9955 -16.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9927 -15.5313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2840 -15.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8711 -15.1264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4557 -15.1268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4591 -14.3090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7522 -13.9006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0436 -14.3094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0464 -15.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7540 -15.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7038 -16.7614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2877 -17.5851 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9953 -17.9939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5799 -17.9935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
18 19 2 0
18 20 1 0
6 18 1 0
M CHG 2 18 1 20 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 293.30 | Molecular Weight (Monoisotopic): 293.0470 | AlogP: 1.98 | #Rotatable Bonds: 4 |
Polar Surface Area: 115.33 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.93 | CX Basic pKa: 0.98 | CX LogP: 2.22 | CX LogD: 2.12 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.51 | Np Likeness Score: -1.96 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |